Document is current

Any future updates will be listed below

Discovery of a potent and orally bioavailable type Ⅰ PRMTs inhibitor for triple-negative breast cancer treatment

Crossref DOI link: https://doi.org/10.1038/s41401-025-01713-5

Published Online: 2026-01-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark